2-HYDROXYPROPYL-BETA-CYCLODEXTRIN Uses, Dosage, Side Effects and more

2-HYDROXYPROPYL-BETA-CYCLODEXTRIN is under investigation in clinical trial NCT03471143 (Study of IV VTS-270 for Infantile Liver Disease Associated With Niemann-Pick Disease, Type C).

Attribute	Details
Trade Name	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN
Generic	Hydroxypropyl betadex
Hydroxypropyl betadex Other Names	2-HYDROXYPROPYL-BETA-CYCLODEXTRIN
Type
Formula	C60H106O40
Weight	Average: 1467.468 Monoisotopic: 1466.626038213
Groups	Investigational
Therapeutic Class
Manufacturer
Available Country
Last Updated:	January 7, 2025 at 1:49 am

Innovators Monograph